普及推广“中国老年性黄斑变性临床诊断治疗路径”，规范老年性黄斑变性的诊断治疗

Promotion and implementing Chinese Clinical Pathway of Age-related Macular Degeneration to standardize the diagnosis and treatment practices of age-related macular degeneration in China

老年性黄斑变性（AMD）是由多种因素诱发的与年龄相关的一组黄斑疾病。随着AMD干预手段不断推陈出新，人们对AMD的认识也在不断深化，但对其了解和干预方式的认识尚不充分。在我国AMD诊断治疗的临床工作，这些矛盾尤为突出。针对AMD诊断治疗面临的这些挑战，制订统一的诊断治疗规范，建立中国的规范化临床诊断治疗流程是提高AMD诊断治疗水平首先需要解决的问题。中华医学会眼科学分会眼底病学组牵头，组织国内眼底病专家基于循证医学依据制订的我国AMD临床路径，对不同阶段、不同亚型的AMD的诊断治疗提出了具有可操作性的临床指南，值得在AMD临床诊断治疗工作中普及推广，并在使用过程中不断完善。规范AMD诊断治疗的临床路径，将有助于引导和规范医师的临床实践，推动AMD诊断治疗研究水平的提高。

Age-related macular degeneration （AMD）, a set of age-related macular disease, is induced by a variety of factors. New intervention methods help us to understand the AMD pathogenesis further~ however, we only have limited knowledge of these novel methods. To improve diagnosis and treatment practices of AMD, it is a priority to propose a standardized clinical procedure of AMD management in China. The Chinese Ocular Fundus Association has just proposed a Chinese AMD clinical pathway based on experts＇ opinions and evidence-based medicine. This clinical guideline is implementable for different stages and subtypes of AMD patients, and hopefully will be updated frequently with more clinical practice. Implementing this AMD pathway in China will improve the quality of clinical practice and research of AMD in China.